12 December 2024 | Thursday | Analysis
In this special edition, we explore the cutting-edge advancements, strategies, and visions shaping the biopharma industry in the year ahead. From analytical innovations in gene therapy to sustainable manufacturing and precision medicine breakthroughs, our thought leaders are redefining what’s possible.
Discover how key players are driving change and addressing the most pressing challenges in biopharma today.
At the Investor Update 2024, Wolfgang Wienand unveiled Lonza's strategic roadmap, emphasizing a focused CDMO business model, a simplified organizational structure, and ambitious growth targets for 2025 and beyond.
Saurabh Singal, CEO & Founder of MoleculeAI, shares insights on transforming early-stage drug discovery, fostering collaborations, and leading AI innovation in biopharma.
Advancing Healthspan for All: Dr. Mehmood Khan Spotlights Aging Science Trends for 2025
Dr. Mehmood Khan, CEO of Hevolution Foundation, highlights aging science breakthroughs, from drug repurposing to AI-driven research. Explore how these innovations aim to extend healthspans globally.
Building a Sustainable Future: Cytiva’s 2025 Roadmap for Transforming Biopharma
Discover how Cytiva is leading the charge in sustainable biomanufacturing, reducing CO2 emissions and integrating eco-design into its innovative solutions.
Shaping the Future of Gene Therapy: Kerstin Pohl on Analytical Innovations for 2025
Kerstin Pohl, SCIEX’s Senior Global Marketing Manager, shares insights on overcoming analytical challenges and enabling high-precision solutions for next-generation gene therapies.
Innovating for Impact: Venkata Indurthi on Aldevron’s Vision for Biomanufacturing in 2025
Venkata Indurthi, CSO at Aldevron, discusses breakthroughs in plasmid DNA production, AI-driven manufacturing, and global expansion strategies to meet biomanufacturing demands.
Redefining Precision Medicine: Demaris Mills on IDT’s Role in Gene Synthesis for 2025
Demaris Mills, President of Integrated DNA Technologies, reveals the latest advancements in CRISPR therapies and sustainable DNA synthesis that are transforming precision medicine.
Shaping Biopharma Purification: Phenomenex’s Vision for 2025
Explore how Phenomenex is advancing chromatography technologies to meet regulatory demands and support the efficient development of complex biotherapeutics.
Stay Updated with the 2025 Latest Trends:
2025 is poised to be a transformative year for biopharma. Stay connected with BioPharma BoardRoom for more insights, strategies, and innovations that are shaping the industry.
© 2025 Biopharma Boardroom. All Rights Reserved.
